ライフサイエンスコーパス: intracardiac

1 echocardiography at 10 min (transesophageal/intracardiac), 24 h, 1 month, and 6 months (transthoraci

2 Intracardiac 4-dimensional flow parameters are novel bio

3 sted OR, 2.25; 95% CI, 1.25-4.03; P = .007), intracardiac abscess (47/144 [32.6%]; adjusted OR, 1.86;

4 confidence interval, 1.21-3.68; P=0.006) and intracardiac abscess (hazard ratio, 2.25; 95% confidence

5 Intracardiac abscess (hazard ratio, 2.93; 95% confidence

6 In S aureus LNVIE, intracardiac abscess and left ventricular ejection fract

7 endently predicted in-hospital mortality and intracardiac abscess and valve perforation independently

8 on in their plasma levels but an increase in intracardiac accumulation of both cytokines.

9 works (CNN) may enable objective analysis of intracardiac activation in AF, which could be applied cl

10 e combination of paced P wave morphology and intracardiac activation sequence can be used for the ide

11 ing to match the P wave morphology and paced intracardiac activation sequence recorded from multiple

12 G at the successful ablation site, and paced intracardiac activation sequence was identical to that o

13 Intracardiac administration of amniotic fluid stem cells

14 CNNs improved the classification of intracardiac AF maps compared with other analyses and ag

15 Intracardiac air was detected on TEE less than 30 second

16 n led to the discovery of massive amounts of intracardiac air which demanded urgent lung isolation an

17 d to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients

18 nsional image using multiple views, evaluate intracardiac anatomy at different depth planes, and recr

19 c burden and extended survival in MDA-MB-231 intracardiac and 4T1 orthotopic (median survival, >80 da

20 d the ability to colonize the bone following intracardiac and direct intratibial injection of athymic

21 gical analysis demonstrated the formation of intracardiac and extracardiac teratomas.

22 Similar results were observed in intracardiac and intratibial models of breast and lung c

23 Intracardiac and pulmonary artery pressure-guided manage

24 es the diagnostic tools for the detection of intracardiac and pulmonary shunts, reviews therapeutic o

25 redominant alpha7-nAChR subtype found in rat intracardiac and superior cervical ganglion neurons exhi

26 eaction techniques in neonatal rat brain and intracardiac and superior cervical ganglion neurons.

27 kg) administered at the time of reperfusion (intracardiac) and then daily (intravenous) for the first

28 ial defect, anterior diaphragmatic defect or intracardiac anomalies.

29 ncreased cardiac fibrosis and suppression of intracardiac anti-fibrotic cytokines, while premenopausa

30 The use of intracardiac assist devices is expanding, and correct po

31 The intracardiac bipolar atrial electrogram recordings were

32 study, all of the rats were euthanized, and intracardiac blood samples and mandible tissues were obt

33 At the end of the study, intracardiac blood samples and mandible tissues were obt

34 An intracardiac cardioverter defibrillator was implanted in

35 d weight < or =70 kg, as well as the lack of intracardiac cardioverter-defibrillator on the day of li

36 reased cardiac inflammation, increased total intracardiac CD45(+) leukocytes, elevated anti-cardiac m

37 natriuretic peptide (NT-proBNP(1-76)) after intracardiac cleavage of their molecular precursor, proB

38 g a diagnosis, and in identifying associated intracardiac complications.

39 o-dimensional echocardiography showed normal intracardiac connections, with the tricuspid valve in th

40 Recognition of intracardiac constant fusion with this method is a novel

41 to assess the exact roles of circulating and intracardiac cytokines in this particular patient popula

42 ria for LBBB incompletely predicted CCB, and intracardiac data might be useful in refining patient se

43 with 5% tilt is delivered to the heart via 2 intracardiac defibrillation leads.

44 p detects evidence of cardiomyopathy, and an intracardiac defibrillator is implanted to reduce the ri

45 yarrhythmias during follow-up and 3 received intracardiac defibrillator shocks for ventricular tachyc

46 mmunosuppressive therapy, and 56 received an intracardiac defibrillator.

47 5+/-8 years, 47% male) without a preexisting intracardiac device or prior valve surgery who underwent

48 ograph images, which can be used to evaluate intracardiac device position.

49 endocarditis include absence of a permanent intracardiac device, sterile follow-up blood cultures wi

50 As the use of intracardiac devices has increased, the awareness of the

51 Infection in the presence of intracardiac devices is a problem of considerable morbid

52 e endocarditis (IE) in prosthetic valves and intracardiac devices is challenging because both the mod

53 pacemaker placement (3 L-loop ventricles, 2 intracardiac devices, 1 double inlet-double outlet RV).

54 rfarin), use (or planned use) of implantable intracardiac devices, and blood pressure control (<140/9

55 ughout institutions that serve patients with intracardiac devices.

56 ensus statement about the ethical removal of intracardiac devices.

57 bout the ethical acceptability of removal of intracardiac devices.

58 Intracardiac ECG revealed that Kcne5 deletion caused ven

59 Surface and intracardiac ECGs revealed prolongation of the PR, QRS,

60 ine catheter for PVI and LAPW ablation under intracardiac echocardiographic guidance.

61 atheter closure under transesophageal and/or intracardiac echocardiographic guidance.

62 eliminated from the adjacent RA under direct intracardiac echocardiographic visualization.

63 catheter at the ostium of the LAA guided by intracardiac echocardiography (167 patients; group 3).

64 lar implantable electronic device leads with intracardiac echocardiography (ICE) during ablation proc

65 t of left atrial (LA) thrombus documented by intracardiac echocardiography (ICE) during LA ablation f

66 e transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) for the diagnosis of

67 to determine the feasibility and accuracy of intracardiac echocardiography (ICE) in guiding percutane

68 Intracardiac echocardiography (ICE) is used to assist at

69 ve of this study was to assess the impact of intracardiac echocardiography (ICE) on the long-term suc

70 All patients underwent PVAI with an intracardiac echocardiography (ICE)-guided approach with

71 using a multipolar Lasso catheter guided by intracardiac echocardiography (ICE).

72 ossible during the procedure with the use of intracardiac echocardiography (ICE).

73 Baseline intracardiac echocardiography (ICE, 10.5F, Siemens), flu

74 ckness measured by NFUS correlated well with intracardiac echocardiography (r=0.86; P<0.0001).

75 d the occurrence of bubble formation seen on intracardiac echocardiography and the microembolic signa

76 ps between the degree of bubble formation on intracardiac echocardiography and the number of MESs (P=

77 a sham procedure (femoral venous access with intracardiac echocardiography but no IASD placement).

78 electroanatomic mapping in conjunction with intracardiac echocardiography demonstrated that 1 of the

79 Intracardiac echocardiography detected all potentially a

80 tion of the PSP-LV with an RA approach under intracardiac echocardiography guidance were performed in

81 Intracardiac echocardiography guided device closure of s

82 The development of intracardiac echocardiography has led to real-time guida

83 hout transesophageal echocardiogram but used intracardiac echocardiography imaging of the appendage f

84 transesophageal echocardiogram screening or intracardiac echocardiography imaging of the appendage i

85 transesophageal echocardiogram screening or intracardiac echocardiography imaging of the appendage;

86 Intracardiac echocardiography imaging was performed in 2

87 Intracardiac echocardiography improves the outcome of co

88 Intracardiac echocardiography is a novel imaging techniq

89 rve as origins of presumed RVOT arrhythmias; intracardiac echocardiography localization of the PV all

90 Intracardiac echocardiography monitored catheter positio

91 Intracardiac echocardiography successfully guided closur

92 rated in vivo using 3-dimensional integrated intracardiac echocardiography to localize the PV.

93 ns were confirmed as supravalvular by direct intracardiac echocardiography visualization.

94 endocardial site of activation under direct intracardiac echocardiography visualization.

95 Intracardiac echocardiography was used to visualize and

96 tion based on PV angiography, 102; guided by intracardiac echocardiography, 140; with energy delivery

97 ls include transesophageal echocardiography, intracardiac echocardiography, intracardiac endoscopy, a

98 Most of this review will be devoted to intracardiac echocardiography, which currently has the b

99 ping, multidetector computed tomography, and intracardiac echocardiography, with arrhythmia foci bein

100 h computed tomography, 3D imaging (NAVX), or intracardiac echocardiography.

101 ing power to microbubble formation guided by intracardiac echocardiography.

102 ntricle) and compared with measurements from intracardiac echocardiography.

103 and ablation approach from the RA guided by intracardiac echocardiography.

104 to the time of fixation, the duration of the intracardiac EGM in ventricular leads increased from 150

105 Intracardiac electrical stimulation revealed that both m

106 ury was characterized as the duration of the intracardiac electrogram (EGM) and the magnitude of ST-s

107 Pacing threshold and intracardiac electrogram amplitude were unchanged over t

108 ucted, which measured T-wave timing using an intracardiac electrogram during a ventricular pacing tra

109 asibility of using real-time, high-fidelity, intracardiac electrogram monitoring from a permanently i

110 nvestigation using real-time, high-fidelity, intracardiac electrogram monitoring from a permanently I

111 Analysis of stored intracardiac electrograms (EGMs) alerts the physician to

112 electrophysiology studies with recording of intracardiac electrograms and atrial and ventricular pac

113 Intracardiac electrograms and pacing parameters were rec

114 graphy, surface ECG and conscious telemetry, intracardiac electrograms and pacing, and optical mappin

115 The intracardiac electrograms atrial/ventricular ratio at th

116 Intracardiac electrograms atrial/ventricular ratio at th

117 n=12), and adapted for sequentially acquired intracardiac electrograms during human persistent atrial

118 The clustering of intracardiac electrograms exhibiting spatiotemporal disp

119 We prospectively analyzed intracardiac electrograms in 125 explanted ICDs.

120 localization was confirmed via recording of intracardiac electrograms in both patients.

121 Bi-atrial intracardiac electrograms of 47 patients with AF at abla

122 g these is the ability to store counters and intracardiac electrograms of individual atrial high-rate

123 The use of intracardiac electrograms to guide atrial fibrillation (

124 Real-time intracardiac electrograms were recorded during MRI.

125 ed shocks from ICDs with stored, retrievable intracardiac electrograms.

126 iate ICD therapies were adjudicated based on intracardiac electrograms.

127 Both groups of transgenic mice underwent intracardiac electrophysiologic, electrocardiographic (E

128 Electrocardiography and intracardiac electrophysiological studies revealed first

129 ECG recordings and intracardiac electrophysiology studies demonstrated the

130 Intracardiac electrophysiology studies with programmed s

131 in type 1 diabetic Akita mice using in vivo intracardiac electrophysiology, high-resolution optical

132 cardiography, intracardiac echocardiography, intracardiac endoscopy, and electroanatomic mapping syst

133 art failure, lower body mass index, elevated intracardiac filling pressures, lower cardiac index, ane

134 a ratio may not be as reliable in predicting intracardiac filling pressures, particularly in those wi

135 reased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a constella

136 rly with pulmonary hypertension and elevated intracardiac filling pressures.

137 cardiac resynchronization therapy underwent intracardiac flow analysis and AVD optimization.

138 e performed quantitative in vivo analyses of intracardiac flow forces in zebrafish embryos.

139 thway in patients with a lateral tunnel (LT) intracardiac Fontan connection and outcomes of percutane

140 Na(V)1.8 labeling in dorsal root ganglia and intracardiac ganglia and only modest Na(V)1.8 expression

141 1.8 staining in isolated neurons from murine intracardiac ganglia but no Na(V)1.8 expression in isola

142 ptide (VIP) have been found within mammalian intracardiac ganglia, but the cellular effects of these

143 heart diseases argues for the importance of intracardiac haemodynamics as a key epigenetic factor in

144 Because cardiac contraction and intracardiac hemodynamic forces can also influence cardi

145 oppler echocardiography accurately estimated intracardiac hemodynamics in these patients supported wi

146 It is well established that intracardiac hemodynamics play a significant role in the

147 is not uncommon and is associated with worse intracardiac hemodynamics, higher B-type natriuretic pep

148 Intracardiac ICD electrograms for subsequent events were

149 The use of intracardiac imaging to guide select cardiac procedures

150 review will propose the features of an ideal intracardiac imaging tool, summarize the intracardiac im

151 eal intracardiac imaging tool, summarize the intracardiac imaging tools that are currently available

152 infections were monitored and compared with intracardiac infections.

153 on of the highest DF site were compared with intracardiac information.

154 in on days 1-4, and hMSCs were delivered via intracardiac infusion on days 10 and 17.

155 India ink intracardiac injection analysis displayed a spectrum of

156 metastasis, we developed a mouse model using intracardiac injection and in vivo selection to isolate

157 xenograft model of lung metastasis and in an intracardiac injection model of experimental bone and lu

158 Melanoma metastasis was induced by intracardiac injection of B16F10 cells.

159 ed greater experimental metastases following intracardiac injection of cancer cells.

160 Indeed, intracardiac injection of Gbeta5-targeted shRNA allowed

161 Intracardiac injection of mesenchymal stromal cells tran

162 We performed intracardiac injection of multiple myeloma (MM) cells de

163 Direct intracardiac injection of the DNA enzyme at the time of

164 Intracardiac injection of two distinct types of adult st

165 onance (MR) imaging that therapy with direct intracardiac injection of vascular endothelial growth fa

166 ow, here we used a novel survivable in utero intracardiac injection technique to deliver a vascular t

167 s in inducing myocardial repair after single intracardiac injection using synthetic lipid formulation

168 ravascular administration of donor cells via intracardiac injection was far more efficient and result

169 ected in the brain vasculature 4 hours after intracardiac injection, and a few adherent cells persist

170 t cancer metastasizes to bone are limited to intracardiac injection, which seeds the cancer cells dir

171 ir ability to colonize in the bone following intracardiac injection, while reexpression of phosphoryl

172 2 mimics for at least 12 days after a single intracardiac injection, with minimal dispersion to other

173 at uses ultrasonographic guidance to perform intracardiac injections.

174 ressive osteolytic lesions within 3 weeks of intracardiac injections.

175 ric mean parasite loads (GMPL) comparable to intracardiac inoculation of 10(7)-10(8) parasites, altho

176 hen experimental metastases were induced via intracardiac inoculation, mice bearing CHO/MIP-1alpha tu

177 istration of cells requires intracoronary or intracardiac instrumentation, which is potentially assoc

178 Beating-heart image-guided intracardiac interventions have been evolving rapidly.

179 Pocket, intravascular and intracardiac lead characteristics on x-ray correlate wit

180 new intracardiac visualization and magnetic intracardiac lead positioning tools are examples of just

181 e ischemia induction in all body-surface and intracardiac leads (P<0.0001).

182 of eliminating the need for intravenous and intracardiac leads and their associated risks and shortc

183 ystem to record and analyze RA from multiple intracardiac leads, and deliver dynamically R-wave trigg

184 For all body surface and intracardiac leads, both Delta(alternans voltage) and De

185 For each mapping point, the intracardiac locations were transferred onto an individu

186 d disorganized regions detected by panoramic intracardiac mapping and correlates with the acute outco

187 We performed detailed intracardiac mapping of left septal conduction to assess

188 Intracardiac mapping was performed to determine the site

189 lts demonstrate that the MGS can be used for intracardiac mapping, pacing, and ablation safely and ef

190 (LVOT) site of origin (SOO) are derived from intracardiac mapping.

191 In group 1, ICE identified intracardiac masses (ICM) in all 44 patients; TEE identi

192 of congenital abnormalities, aortic disease, intracardiac masses, and pericardial disease.

193 nclude the detection and characterization of intracardiac masses, thrombi, myocarditis, and sarcoidos

194 tect subtle F-wave variability, validated by intracardiac measurements.

195 Intracardiac monitoring was performed in 37 patients at

196 Intracardiac monitoring with real-time alarms for ST-seg

197 We have shown that the intracardiac nervous system in the zebrafish is anatomic

198 In the vertebrate heart the intracardiac nervous system is the final common pathway

199 The intracardiac nervous system represents the final common

200 Depolarization of intracardiac neurons by the neuropeptides was dependent

201 ntestinal polypeptide (VIP) is released from intracardiac neurons during vagal stimulation, ischemia,

202 2+]i and neuroexcitability, respectively, in intracardiac neurons of neonatal rats.

203 The mean total number of intracardiac neurons was 713 +/- 78 (SE), nearly half of

204 ting [Ca2+]i, both PACAP and VIP depolarized intracardiac neurons, and PACAP was further shown to aug

205 reduced action potential firing frequency in intracardiac neurons, confirming a functional role for N

206 he functional presence of SCN10A/Na(V)1.8 in intracardiac neurons, indicating a novel role for this n

207 tly through cardiomyocytes or indirectly via intracardiac neurons.

208 s but significantly reduced I(Na) density in intracardiac neurons.

209 ergistically to enhance neuroexcitability in intracardiac neurons.

210 tic, and sensory-motor nerves, as well as in intracardiac neurons.

211 istic standpoint, nitrite treatment restored intracardiac nitrite and increased S-nitrosothiol levels

212 of 5 patients were well without evidence of intracardiac or extracardiac amyloid accumulation, and m

213 wth of metastatic brain tumors introduced by intracardiac or intracranial injection of breast cancer

214 th venous thromboembolism in the presence of intracardiac or pulmonary shunts.

215 hat IDAFL and NIDAFL lie along a spectrum of intracardiac organization.

216 e III collagen synthesis identified cells of intracardiac origin as the main source for collagen turn

217 ms that induce fibrillogenesis of cells with intracardiac origin.

218 al trauma is mainly driven by fibroblasts of intracardiac origin.

219 spleen was determined by real-time PCR after intracardiac perfusion.

220 were returned to their cages for 1 h before intracardiac perfusion.

221 assessment of the relationship between daily intracardiac pressure and occurrence of ventricular arrh

222 Elevated intracardiac pressure attributable to heart failure indu

223 ric heart transplant (HT) patients, expected intracardiac pressure measurements in patients free of s

224 re (HF) management strategy using continuous intracardiac pressure monitoring could decrease HF morbi

225 High-fidelity intracardiac pressure waveforms from 100 consecutive pat

226 fibrosis, by monitoring echocardiography and intracardiac pressure-volume relationships and myocardia

227 Echocardiography easily can measure intracardiac pressures accurately but in a static fashio

228 Among patients with VT/VF, elevated intracardiac pressures are associated with higher VT/VF

229 Intracardiac pressures are elevated in the early post-HT

230 the Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients with Chronic Heart Fa

231 do not contribute to differences in expected intracardiac pressures in the first year post-HT.

232 A better understanding of the range of intracardiac pressures in these HT patients is important

233 We analyzed intracardiac pressures measured in the first 12 mo after

234 PVP and intracardiac pressures were obtained by transducing a pe

235 on >/= 50%, increased natriuretic peptide or intracardiac pressures, and reduced exercise capacity.

236 P and RCMP patients had similar elevation in intracardiac pressures.

237 ry, and has been used to perform portions of intracardiac procedures via thoracotomy incisions.

238 rdiographic imaging, calibrated to panoramic intracardiac recordings and referenced to AF termination

239 The targets comprise myofibroblasts, intracardiac renin-angiotensin axis, matrix metalloprote

240 AT were univentricular physiology, previous intracardiac repair, systemic right ventricle, pulmonary

241 entricular lead placement (n=10) followed by intracardiac right-to-left shunt (n=5).

242 An intracardiac right-to-left shunt (RLS) could allow large

243 factor-kappaB ligand, were injected via the intracardiac route into both wild-type and OPN-/- mice.

244 the form of thromboembolism, dissection and intracardiac shunting and mass effect over adjacent card

245 tal myocyte proliferation by manipulation of intracardiac shunting at the atrial level.

246 ume and flow, either globally (left-to-right intracardiac shunting) or from flow and volume diversion

247 No intracardiac shunts were found with echocardiography alo

248 Eight intracardiac shunts were identified, four of which were

249 us cardiopulmonary conditions, patients with intracardiac shunts, and special patient populations inc

250 CHF and in patients with large left-to-right intracardiac shunts.

251 tion and in infants with large left-to-right intracardiac shunts.

252 Intracardiac signal transduction involves: adenosine, br

253 lutter wave morphology and limited recording intracardiac sites proved insufficient to delineate the

254 We report the first clinical studies of intracardiac ST-segment monitoring in ambulatory humans

255 Shifts exceeding 3 SD from a patient's daily intracardiac ST-segment range may be a sensitive/specifi

256 The ECG analyses were compared with intracardiac standard deviations of: 1) atrial electrogr

257 the image quality of native valves and other intracardiac structures.

258 expression, whereas the ganglion is the only intracardiac target of NO, we hypothesize that NO serves

259 Fifth-eight intracardiac thrombi were identified in 42 patients (27%

260 Intracardiac thrombosis occurs frequently in cardiac amy

261 Intracardiac thrombosis was identified in 38 hearts (33%

262 A high frequency of intracardiac thrombosis was present in cardiac amyloidos

263 /transesophageal echocardiographic risks for intracardiac thrombosis, and effect of anticoagulation w

264 The prevalence of intracardiac thrombosis, clinical and transthoracic/tran

265 pendently associated with increased risk for intracardiac thrombosis, whereas anticoagulation was ass

266 dulthood, they eventually succumb to massive intracardiac thrombosis.

267 oidosis, the AL group had significantly more intracardiac thrombus (51% versus 16%, P<0.001) and more

268 R], 91.6; P=0.0041) and clinically diagnosed intracardiac thrombus (HR, 22.7; P=0.0002).

269 Arrhythmias, conduction abnormalities, and intracardiac thrombus are common in patients with cardia

270 e than echocardiography for the detection of intracardiac thrombus because of its unique ability to i

271 ation rate mainly due to a high incidence of intracardiac thrombus even among patients who received a

272 ocardial function, which could predispose to intracardiac thrombus formation.

273 valence nor the effect of anticoagulation on intracardiac thrombus has been evaluated antemortem.

274 Although intracardiac thrombus has been reported in anecdotal cas

275 ompared with control patients, mainly due to intracardiac thrombus identified on transesophageal echo

276 We recently reported a high prevalence of intracardiac thrombus in cardiac amyloid patients at aut

277 0.02); 4 of 13 of the CA patients (31%) with intracardiac thrombus on transesophageal echocardiogram

278 AL amyloid had more frequent intracardiac thrombus than the other types (35% versus 1

279 early acute cardioversion (in the absence of intracardiac thrombus) with postcardioversion anticoagul

280 fied into 2 groups: systemic TEC, defined as intracardiac thrombus, ischemic stroke, or systemic arte

281 h-risk patients may allow early detection of intracardiac thrombus.

282 Control hearts had no intracardiac thrombus.

283 Each heart was examined for intracardiac thrombus.

284 acute ischaemic stroke and patients with an intracardiac thrombus.

285 A leadless intracardiac transcatheter pacing system has been design

286 We tested the hypothesis that intracardiac transplantation of autologous bone marrow-

287 the murine host with cyclophosphamide before intracardiac tumor cell inoculation was found to signifi

288 2 transseptal punctures were performed under intracardiac ultrasound (ICE) guidance, with one of the

289 Both fluoroscopy and intracardiac ultrasound (ICE)-guided balloon and Lasso c

290 function was studied with intravascular and intracardiac ultrasound.

291 pedance signals, utilizing intrathoracic and intracardiac vectors, were measured through ring (r), co

292 Patients with intracardiac vegetations are at high risk for complicati

293 One hundred patients had intracardiac vegetations identified by transesophageal e

294 n patients at a tertiary care center who had intracardiac vegetations identified by transesophageal e

295 Patients with intracardiac vegetations identified on transesophageal e

296 The presence of intracardiac vegetations identifies a subset of patients

297 patients with echocardiographic evidence of intracardiac vegetations, followed by a descriptive and

298 s incorporated into the catheters, measuring intracardiac ventricular electrograms, and integrating t

299 tools, guiding catheters, stenting, and new intracardiac visualization and magnetic intracardiac lea

300 tron-emission tomography (PET) imaging; (2.) intracardiac voltage mapping with visible lesion on ultr